SCHEMBL31340923

SCHEMBL31340923

CO[C@@H]1C[C@H](C(=O)N(C)OC)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.53
NR1H2 P55055 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
HSD17B10 Q99714 1/20 0.32
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
HSD11B1 P28845 2/20 0.31
HTRA1 Q92743 1/20 0.31
MCL1 Q07820 1/20 0.31
P2RX3 P56373 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30501862 1.00 UCHL1 (0.53) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL25619159 1.00 UCHL1 (0.53) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL27393752 1.00 UCHL1 (0.53) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL18538108 1.00 UCHL1 (0.53) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL18577227 0.91 UCHL1 (0.45) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL18577225 0.91 UCHL1 (0.45) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL5359255 0.89 UCHL1 (0.54) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL31573208 0.87 UCHL1 (0.43) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL8212932 0.86 UCHL1 (0.42) UCHL1NR1H2CYP1A2POLBCYP3A4
SCHEMBL13103213 0.86 UCHL1 (0.38) UCHL1NR1H2CYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747250-A1 KINASE INHIBITORS The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) 2026-05-27 EP disclosed
WO-2025019585-A1 KINASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-23 WO disclosed